Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Astrana Health, Inc.ASTH · Entity 4538 | Director | June 10, 2026 | June 12, 2026 |
| Fulgent Genetics, Inc.FLGT · Entity 2545 | Director | May 14, 2026 | May 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Astrana Health, Inc.
Report date June 10, 2026 · Filed June 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 97,133 |
Reported balance
After 2026-06-10 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-10 · Grant · Acquired 4,525 · Balance 97,133 F1: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. F2: Includes 4,525 shares of restricted stock, which will vest on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.
F2: Includes 4,525 shares of restricted stock, which will vest on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders.
Fulgent Genetics, Inc.
Report date May 14, 2026 · Filed May 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 38,758 |
Reported balance
After 2026-05-14 transaction · row 1
1 source rowRow 1 · 2026-05-14 · Grant · Acquired 11,117 · Balance 38,758 F1: Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after May 14, 2026, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after May 14, 2026, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2026 Filed Jun 12, 2026 20:19 UTC | Astrana Health, Inc. ASTH · Entity 4538 | GrantCommon Stock | 4,525 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-073484 · tm2617575-3_4seq1.xml · nonDerivative · entry 1 Dong Linda · CIK 0001765204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,133 F1 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. F2 · balance_after: Includes 4,525 shares of restricted stock, which will vest on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders. Read SEC document |
| May 14, 2026 Filed May 18, 2026 22:30 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | GrantCommon Stock | 11,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001765204-26-000004 · ownership.xml · nonDerivative · entry 1 Dong Linda · CIK 0001765204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,758 F1 · shares: Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after May 14, 2026, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date. Read SEC document |
| November 03, 2025 Filed Nov 6, 2025 00:44 UTC | Astrana Health, Inc. ASTH · Entity 4538 | Exercise / conversionStock Option (right to Buy) · Derivative | 20,000 | $0.00 Strike: $18.20 | $0.00 |
DisclosureSEC source: 0001104659-25-107189 · tm2530332-1_4seq1.xml · derivative · entry 3 Marsh Linda · CIK 0001765204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2025-11-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These stock options were fully vested and exercisable. Read SEC document |
| November 03, 2025 Filed Nov 6, 2025 00:44 UTC | Astrana Health, Inc. ASTH · Entity 4538 | Tax withholdingCommon Stock | 11,033 | $32.99 | $363,978.67 |
DisclosureSEC source: 0001104659-25-107189 · tm2530332-1_4seq1.xml · nonDerivative · entry 2 Marsh Linda · CIK 0001765204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,608 F1 · balance_after: Includes 6,449 shares of restricted stock, which will vest on the earlier of June 11, 2026 or the date of the Issuer's 2026 annual meeting of stockholders. Read SEC document |
| November 03, 2025 Filed Nov 6, 2025 00:44 UTC | Astrana Health, Inc. ASTH · Entity 4538 | Exercise / conversionCommon Stock | 20,000 | $18.20 | $364,000.00 |
DisclosureSEC source: 0001104659-25-107189 · tm2530332-1_4seq1.xml · nonDerivative · entry 1 Marsh Linda · CIK 0001765204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,641 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 20:20 UTC | Astrana Health, Inc. ASTH · Entity 4538 | GrantCommon Stock | 6,449 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-059377 · tm2517874-5_4seq1.xml · nonDerivative · entry 1 Marsh Linda · CIK 0001765204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,641 F1 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 11, 2026 or (ii) the date of the Issuer's 2026 annual meeting of stockholders. F2 · balance_after: Includes 6,449 shares of restricted stock, which will vest on the earlier of June 11, 2026 or the date of the Issuer's 2026 annual meeting of stockholders. Read SEC document |
| May 15, 2025 Filed May 19, 2025 23:29 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | GrantCommon Stock | 8,982 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-074718 · ownership.xml · nonDerivative · entry 1 Marsh Linda · CIK 0001765204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,641 F1 · shares: Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after May 15, 2025, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date. Read SEC document |
| September 10, 2024 Filed Sep 12, 2024 21:03 UTC | Astrana Health, Inc. ASTH · Entity 4538 | Exercise / conversionStock Option (right to buy) · Derivative | 11,000 | $0.00 Strike: $15.35 | $0.00 |
DisclosureSEC source: 0001104659-24-099376 · tm2423950-1_4seq1.xml · derivative · entry 3 Marsh Linda · CIK 0001765204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,000 shares Expires 2024-10-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These stock options were fully vested and exercisable. Read SEC document |
| September 10, 2024 Filed Sep 12, 2024 21:03 UTC | Astrana Health, Inc. ASTH · Entity 4538 | Tax withholdingCommon Stock | 3,522 | $47.93 | $168,809.46 |
DisclosureSEC source: 0001104659-24-099376 · tm2423950-1_4seq1.xml · nonDerivative · entry 2 Marsh Linda · CIK 0001765204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,192 F2 · balance_after: Includes 3,650 shares of restricted stock, which will vest on December 9, 2024, and 3,564 shares of restricted stock, which will vest on the earlier of August 13, 2025 or the date of the Issuer's 2025 annual meeting of stockholders. Read SEC document |
| September 10, 2024 Filed Sep 12, 2024 21:03 UTC | Astrana Health, Inc. ASTH · Entity 4538 | Exercise / conversionCommon Stock | 11,000 | $15.35 | $168,850.00 |
DisclosureSEC source: 0001104659-24-099376 · tm2423950-1_4seq1.xml · nonDerivative · entry 1 Marsh Linda · CIK 0001765204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,714 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 13, 2024 Filed Aug 14, 2024 20:39 UTC | Astrana Health, Inc. ASTH · Entity 4538 | GrantCommon Stock | 3,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-089699 · tm2421691-6_4seq1.xml · nonDerivative · entry 1 Marsh Linda · CIK 0001765204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,714 F1 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) August 13, 2025 or (ii) the date of the Issuer's 2025 annual meeting of stockholders. F2 · balance_after: Includes 3,650 shares of restricted stock, which will vest on December 9, 2024, and 3,564 shares of restricted stock, which will vest on the earlier of August 13, 2025 or the date of the Issuer's 2025 annual meeting of stockholders. Read SEC document |
| May 16, 2024 Filed May 20, 2024 22:04 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-062569 · ownership.xml · nonDerivative · entry 1 Marsh Linda · CIK 0001765204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,659 F1 · shares: Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after May 16, 2024, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date. Read SEC document |
| December 15, 2023 Filed Dec 18, 2023 21:36 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantCommon Stock | 3,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-126904 · tm2333076-6_4seq1.xml · nonDerivative · entry 1 Marsh Linda · CIK 0001765204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,150 F1 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan, which shall vest on December 9, 2024 (or if earlier, upon the date of the Reporting Person's cessation of service on the Issuer's board of directors). F2 · balance_after: Includes 3,650 shares of restricted stock, which will vest on December 9, 2024. Read SEC document |
| May 18, 2023 Filed May 22, 2023 20:38 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | GrantCommon Stock | 5,059 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-031477 · doc4.xml · nonDerivative · entry 1 Marsh Linda · CIK 0001765204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,659 F1 · shares: Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after May 18, 2023, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date. Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 20:32 UTC | Astrana Health, Inc. AMEH · Entity 4538 | Disposition to issuerCommon Stock | 270,081 | $35.32 | $9,539,260.92 |
DisclosureSEC source: 0001628280-23-008109 · wf-form4_167891236085499.xml · nonDerivative · entry 1 Marsh Linda · CIK 0001765204 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Alliance Apex, LLC Disclosed balance after: 0 F1 · ownership.nature: These shares are owned directly by Alliance Apex, LLC, of which Reporting Person is a member and the sole manager. Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein, and the filing of this report is not an admission that Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 16:40 UTC | Astrana Health, Inc. AMEH · Entity 4538 | Exercise / conversionStock Option (right to buy) · Derivative | 62,500 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001250853-23-000009 · primary_doc.xml · derivative · entry 5 Marsh Linda · CIK 0001765204 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62,500 shares Expires 2023-04-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options were granted on March 4, 2020 and vested and became exercisable on the date of the grant. Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 16:40 UTC | Astrana Health, Inc. AMEH · Entity 4538 | Exercise / conversionCommon Stock | 62,500 | $10.00 | $625,000.00 |
DisclosureSEC source: 0001250853-23-000009 · primary_doc.xml · nonDerivative · entry 1 Marsh Linda · CIK 0001765204 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 21:42 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | GrantCommon Stock | 1,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-044294 · doc4.xml · nonDerivative · entry 1 Marsh Linda · CIK 0001765204 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,600 F1 · shares: Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after August 1, 2022, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date. Read SEC document |
| June 17, 2022 Filed Jun 18, 2022 00:26 UTC | Astrana Health, Inc. AMEH · Entity 4538 | SaleCommon Stock | 250,000 | $37.00 | $9,250,000.00 |
DisclosureSEC source: 0001104659-22-072514 · tm2218854d2_4.xml · nonDerivative · entry 1 Marsh Linda · CIK 0001765204 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Alliance Apex, LLC Disclosed balance after: 270,081 F1 · ownership.nature: These shares are owned directly by Alliance Apex, LLC, of which Reporting Person is a member and the sole manager. Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein, and the filing of this report is not an admission that Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:04 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | GrantCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-030961 · doc4.xml · nonDerivative · entry 1 Marsh Linda · CIK 0001765204 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 F1 · shares: Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after May 18, 2022, and 1/16th of such shares vesting at the end of every three-month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date. Read SEC document |
| January 20, 2022 Filed Jan 24, 2022 23:01 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantStock Option (right to buy) · Derivative | 8,500 | $0.00 Strike: $53.01 | $0.00 |
DisclosureSEC source: 0001250853-22-000030 · primary_doc.xml · derivative · entry 1 Marsh Linda · CIK 0001765204 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,500 Underlying: Common Stock · 8,500 shares Expires 2025-01-18 F1 · derivative.exercise_date: The option vests in four equal quarterly installments from January 18, 2022. Read SEC document |
| May 20, 2021 Filed May 24, 2021 21:26 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | GrantCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-035452 · doc4.xml · nonDerivative · entry 1 Marsh Linda · CIK 0001765204 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 F1 · shares: Reflects an award of restricted stock units relating to 2,000 shares of the Issuer's common stock. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after May 20, 2021, and 1/16th of such shares vesting every three months over the remaining 36 months, subject to the reporting person's continued service for Issuer on each vesting date. Read SEC document |
| November 11, 2020 Filed Nov 14, 2020 01:39 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $18.20 | $0.00 |
DisclosureSEC source: 0001250853-20-000105 · primary_doc.xml · derivative · entry 1 Marsh Linda · CIK 0001765204 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2025-11-11 F1 · derivative.exercise_date: The option vests in four equal quarterly installments from the option grant date. Read SEC document |
| May 27, 2020 Filed May 28, 2020 16:42 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $15.82 | $0.00 |
DisclosureSEC source: 0001209191-20-032548 · doc4.xml · derivative · entry 1 Marsh Linda · CIK 0001765204 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2030-05-26 F1 · derivative.exercise_date: The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 27, 2020, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to Ms. Marsh's continued service for the Issuer on each vesting date. Read SEC document |
| March 04, 2020 Filed Mar 13, 2023 16:40 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantStock Option (right to buy) · Derivative | 62,500 | Not disclosed Strike: $10.00 | Not disclosed |
DisclosureSEC source: 0001250853-23-000009 · primary_doc.xml · derivative · entry 4 Marsh Linda · CIK 0001765204 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,500 Underlying: Common Stock · 62,500 shares Expires 2023-04-05 F2 · kind: The transactions reported on Lines 1 and 2 involved an amendment of an outstanding option, resulting in the cancellation of the original option and the grant of a replacement option. The option was originally granted on April 5, 2017 and vested and became exercisable on a monthly basis over thirty six months commencing on May 5, 2017. F2 · price: The transactions reported on Lines 1 and 2 involved an amendment of an outstanding option, resulting in the cancellation of the original option and the grant of a replacement option. The option was originally granted on April 5, 2017 and vested and became exercisable on a monthly basis over thirty six months commencing on May 5, 2017. F2 · derivative.exercise_date: The transactions reported on Lines 1 and 2 involved an amendment of an outstanding option, resulting in the cancellation of the original option and the grant of a replacement option. The option was originally granted on April 5, 2017 and vested and became exercisable on a monthly basis over thirty six months commencing on May 5, 2017. Read SEC document |
| March 04, 2020 Filed Mar 13, 2023 16:40 UTC | Astrana Health, Inc. AMEH · Entity 4538 | Disposition to issuerStock Option (right to buy) · Derivative | 62,500 | Not disclosed Strike: $10.00 | Not disclosed |
DisclosureSEC source: 0001250853-23-000009 · primary_doc.xml · derivative · entry 3 Marsh Linda · CIK 0001765204 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62,500 shares Expires 2020-04-05 F2 · kind: The transactions reported on Lines 1 and 2 involved an amendment of an outstanding option, resulting in the cancellation of the original option and the grant of a replacement option. The option was originally granted on April 5, 2017 and vested and became exercisable on a monthly basis over thirty six months commencing on May 5, 2017. F2 · price: The transactions reported on Lines 1 and 2 involved an amendment of an outstanding option, resulting in the cancellation of the original option and the grant of a replacement option. The option was originally granted on April 5, 2017 and vested and became exercisable on a monthly basis over thirty six months commencing on May 5, 2017. F2 · derivative.exercise_date: The transactions reported on Lines 1 and 2 involved an amendment of an outstanding option, resulting in the cancellation of the original option and the grant of a replacement option. The option was originally granted on April 5, 2017 and vested and became exercisable on a monthly basis over thirty six months commencing on May 5, 2017. Read SEC document |
| October 11, 2019 Filed Nov 20, 2019 19:20 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantStock Options · Derivative | 11,000 | $0.00 Strike: $15.35 | $0.00 |
DisclosureSEC source: 0001104659-19-065776 · tm1923454d5_4.xml · derivative · entry 1 Marsh Linda · CIK 0001765204 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,500 Underlying: Common Stock · 11,000 shares Expires 2024-10-11 F1 · derivative.exercise_date: The Issuer granted these options to Reporting Person in consideration for her service as a director of the Issuer. Such stock options vest in 4 installments on January 11, 2020; April 11, 2020; July 11, 2020; and October 11, 2020. F1 · derivative.expiration_date: The Issuer granted these options to Reporting Person in consideration for her service as a director of the Issuer. Such stock options vest in 4 installments on January 11, 2020; April 11, 2020; July 11, 2020; and October 11, 2020. Read SEC document |
| August 01, 2019 Filed Aug 5, 2019 13:17 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $7.56 | $0.00 |
DisclosureSEC source: 0001209191-19-044388 · doc4.xml · derivative · entry 1 Marsh Linda · CIK 0001765204 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-08-01 F1 · derivative.exercise_date: The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after August 1, 2019, and 1/16th of the remaining shares vesting at the end of every three-month period over the remaining 36 months, subject to Ms. Marsh's continued service for the Predecessor or the Issuer on each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.